MicroRNA profiles discriminate among colon cancer metastasis

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Drusco, Alessandra ^a   Nuovo, Gerard J ^a   Zanesi, Nicola ^a   Di Leva, Gianpiero ^a   Pichiorri, Flavia ^a   Volinia, Stefano ^a,b   Fernandez, Cecilia ^a   Antenucci, Anna ^c   Costinean, Stefan ^a   Bottoni, Arianna ^a   Rosito, Immacolata A ^c   Liu, Chang Gong ^d   Burch, Aaron ^a   Acunzo, Mario ^a   Pekarsky, Yuri ^a   Alder, Hansjuerg ^a   Ciardi, Antonio ^e   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF FERRARA   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF TEXAS   (United States)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 21; MICRORNA 31; MICRORNA 566; MICRORNA 93; UNCLASSIFIED DRUG; TRANSCRIPTOME; TUMOR MARKER;

ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; PREDICTIVE VALUE; PRIMARY TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA GENE; TISSUE DISTRIBUTION; TISSUE MICROARRAY; TUMOR INVASION; UPREGULATION; ADENOCARCINOMA; COLON TUMOR; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; SECONDARY;

ADENOCARCINOMA; COLONIC NEOPLASMS; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MICRORNAS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84903372765     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096670     Document Type: Article

References (95)

1. Gupta GP, Massagué J (2006) Cancer Metastasis: building a framework. Cell 127(4): 679-695. (Pubitemid 44781029)
2. Riethmüller G, Klein CA (2001), Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. Semin Cancer Biol 11(4): 307-311. (Pubitemid 32799908)
3. MacKie RM, Reid R, Junor B (2003) Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med 348(6): 567-568. (Pubitemid 36159900)
4. Ulmer A, Fischer JR, Schanz S, Sotlar K, Breuninger H, et al. (2005) Detection of melanoma cells displaying multiple genomic changes in histologically negative sentinel lymph nodes. Clin Cancer Res 11(15):5425-32. (Pubitemid 41060817)
5. Pantel K, Alix-Panabières C, Riethdorf S (2009) Cancer micrometastase. Nat Rev Clin Oncol 6(6): 339-351.
6. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2): 74-108. (Pubitemid 40372904)
7. Eggermont AM (2000) Adjuvant therapy of malignant melanoma and the role of sentinel node mapping. Recent Results Cancer Res 157: 178-189.
8. Weiser MR, Landmann RG, Kattan MW, Gonen M, Shia J, et al. (2008) Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 26(3): 380-385. (Pubitemid 351171688)
9. Salhab M, Patani N, Mokbel K (2011) Sentinel lymph node micrometastasis in human breast cancer: an update. Surg Oncol 20(4): e195-e206.
10. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA (2003) Diagnostic and therapeutic management of cancer of unknown primary. Eur J Cancer 39(14): 1990-2005. (Pubitemid 37297755)
11. Edmonson H, Craig J, Shiff L, Shiff E (1987) Neoplasms of the liver Philadelphia: JB Lppincott. 1109-1116.
12. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
13. Calin GA, Croce CM (2006) MicroRNAs signature in human cancer. Nat Rev Cancer 6: 857-866.
14. Cho WC (2007) OncomiRNAs: the discovery and progress of microRNAs in cancer. Mol Cancer 6: 60.
15. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, et al. (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98(26): 15149-15154. (Pubitemid 34013984)
16. Lu J, Getz G, Miaka EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancer. Nature 435(7043): 834-838. (Pubitemid 40839735)
17. Ma XJ, Patel R, Wang X, Salunga R, Murage J, et al. (2006) Molecular classification of human cancer using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med 139(4): 465-473.
18. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors define cancer gene targets. Proc Natl Acad Sci USA 103(7):2257-2261. (Pubitemid 43271657)
19. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, et al. (2008) MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26(4): 462-469. (Pubitemid 351501813)
20. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, et al. (2004) An oligonucleotide microchip for genome wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101: 9740-4 (Pubitemid 38869306)
21. Liu CG, Calin GA, Volinia S, Croce CM (2008) MicroRNA expression profiling using microarrays. Nat Protoc 3(4): 563-578. (Pubitemid 351516752)
22. Simon R, Lam A, Li MC, Ngan M, Menenzes S, et al. (2007) Analysis of gene expression data using BRBArrayTools. Cancer Informatics 3: 11-17. (Pubitemid 47075796)
23. Wright JW, Simon RM (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19: 2448-55.
24. Nuovo GJ (2008) In situ detection of precursor and mature microRNAs in paraffin embedded, formalin fixed tissue and cell preparations. Methods 44: 39-46.
25. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, et al. (2010) A MicroRNA targeting dicer for metastasis control. Cell 141(7): 1195-1207.
26. Choi HK, Law WL, Poon JT (2010) The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes. BMC Cancer 10: 267.
27. Poritz LS, Sehgal R, Hartnett K, Berg A, Koltun WA (2011) Tumor volume and percent positive lymph nodes as a predictor of 5-year survival in colorectal cancer. Surgery 150(4): 649-655.
28. Storli KE, Søndenaa K, Bukholm IR, Nesvik I, Bru T, et al. (2011) Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old age. Int J Colorectal Dis 26(10): 1299-1307.
29. Weiser MR, Gönen M, Chou JF, Kattan MW, Schrag D (2011) Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. J Clin Oncol 29(36): 4796-4802.
30. O'Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96(19): 1420-1425. (Pubitemid 39429665)
31. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68(15): 6416-6424.
32. Weiser MR, Landmann RG, Kattan MW, Gonen M, Shia J, et al. (2008) Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 26(3):380-5. (Pubitemid 351171688)
33. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, et al. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55 Suppl 3: iii1-8. (Pubitemid 44085662)
34. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, et al. (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244(2): 254-259. (Pubitemid 44305540)
35. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, et al. (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94(7): 982-999.
36. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, et al. (2009) Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9: 401.
37. Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, et al. (2009) Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 26(1): 27-34.
38. Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY, et al. (2010) miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 70(4): 1635-1644.
39. Wong QW, Lung RW, Law PT, Lai PB, Chan KY, et al. (2008) MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 135(1): 257-69. (Pubitemid 351910680)
40. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, et al. (2008) Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 14(9): 2588-2592.
41. Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, et al. (2010) MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 120(4): 1298-1309.
42. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, et al. (2009) A pleiotropically acting microRNA, miR-31, nihilist breast cancer metastases. Cell 137(6): 1032-1046.
43. Creighton CJ, Fountain MD, Yu Z, Nagaraja AK, Zhu H, et al. (2010) Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res 70(5): 1906-1915.
44. Zhang Y, Guo J, Li D, Xiao B, Miao Y, et al. (2010) Downregulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med Oncol 27(3): 685-689.
45. Wszolek MF, Rieger-Christ KM, Kenney PA, Gould JJ, Silva Neto B, et al. (2011) A MicroRNA expression profile defining the invasive bladder tumor phenotype. Urol Oncol 29(6): 794-801.
46. Cottonham CL, Kaneko S, Xu L (2010) miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem 285(46): 35293-35302.
47. Wang CJ, Stratmann J, Zhou ZG, Sun XF (2010) Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells. BMC Cancer 10: 616.
48. Pedrioli DM, Karpanen T, Dabouras V, Jurisic G, van de Hoek G, et al. (2010) miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo. Mol Cell Biol 30(14): 3620-3634.
49. Suárez Y, Wang C, Manes TD, Pober JS (2010) Cutting edge: TNF-induced microns regulate TNF-induced espresso of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol 184(1): 21-25.
50. Lu TX, Munitz A, Rothenberg ME (2009) MicroRNA-21 is upregulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 182: 4994-5002.
51. Schetter AJ, Nguyen GH, Bowman ED, Mathé EA, Yuen ST, et al. (2009) Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res 15(18): 5878-5887.
52. Schetter AJ, Heegaard NH, Harris CC (2010) Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31(1): 37-49.
53. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, et al. (2010) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11: 141-147.
54. Triantafilou M, Triantafilou K (2002) Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 23: 301-304. (Pubitemid 34628773)
55. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, et al. (2007) miRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2: 1020.
56. Chen RF, Huang HC, Ou CY, Hsu TY, Chuang H, et al. (2010) MicroRNA-21 expression in neonatal blood associated with antenatal immunoglobulin E production and development of allergic rhinitis. Clin Exp Allergy 40: 1482-1490.
57. Van der Fits L, van Kester MS, Qin Y, Out-Luiting JJ, Smit F, et al (2011) MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in sezary syndrome. J Invest Dermatol 131: 762-768.
58. Chen PY, Manninga H, Slanchev K, Chien M, Russo JJ, et al. (2005) The developmental miRNA profiles of zebrafish as determined by small RNA cloning. Genes Dev 19(11): 1288-1293. (Pubitemid 41003018)
59. Ramachandra RK, Salem M, Gahr S, Rexroad CE 3rd, Yao J (2008) Cloning and characterization of microRNAs from rainbow trout (Oncorhynchus mykiss): their expression during early embryonic development. BMC Dev Biol 8: 41.
60. Singh SK, Kagalwala MN, Parker-Thornburg J, Adams H, Majumder S (2008) REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 453(7192): 223-227. (Pubitemid 351667975)
61. Hayashi T, Koyama N, Azuma Y, Kashimata M (2011) Mesenchymal mir-21 regulates branching morphogenesis in murine submandibular gland in vitro. Dev Biol 352(2): 299-307.
62. Liu LZ, Li C, Chen Q, Jing Y, Carpenter R., et al. (2011) MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1a expression. PLoS One 6(4): e19139.
63. Donnem T, Fenton CG, Lonvik K, Berg T, Eklo K, et al. (2012) MicroRNA signatures in tumor tissue related to angiogenesis in Non-Small Cell lung cancer. PLoS One 7(1): e29671 (Epub 2012 Jan 25).
64. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65(14), 6029-6033. (Pubitemid 40994386)
65. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16): 7065-7070. (Pubitemid 41161233)
66. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 67(18): 8699-8707. (Pubitemid 47437445)
67. Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, et al. (2007) MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 121(5): 1156-1161. (Pubitemid 47101656)
68. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, et al. (2007) Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120(5): 1046-1054. (Pubitemid 46214304)
69. Lui WO, Pourmand N, Patterson BK, Fire A (2007) Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67(13): 6031-6043. (Pubitemid 47037482)
70. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, et al. (2008) MicroRNA-21(miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 27; 2128-2136. (Pubitemid 351485639)
71. Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, et al. (2008) MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123(12); 2791-2797.
72. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, et al. (2008) Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14(2): 419-427. (Pubitemid 351226109)
73. Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, et al. (2008) MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA 105(35): 12885-12890.
74. Zhang Z, Li Z, Gao C, Chen P, Chen J, et al. (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88(12): 1358-1366.
75. Zhu S, Wu H, Wu F, Nie D, Sheng S, et al. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18; 350-359. (Pubitemid 351333899)
76. Medina PP, Nolde M, Slack FJ (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-Bcell lymphoma. Nature 467: 86-90.
77. Neely LA, Rieger-Christ KM, Neto BS, Eroshkin A, Garver J, et al. (2010) A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol 28(1): 39-48.
78. Grunder E, D'Ambrosio R, Fiaschetti G, Abela L, Arcaro A, et al. (2011) MicroRNA-21 suppression impedes medulloblastoma cell migration. Eur J Cancer 47(16): 2479-2490.
79. Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sañudo A, et al. (2011) MicroRNA expression profiles in the progression of prostate cancer-from high-grade prostate intraepithelial neoplasia to metastasis. Urol Oncol Aug 29 (Epub ahead of print).
80. Yang CH, Yue J, Pfeffer SR, Handorf CR, Pfeffer LM (2011) MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem 286(45): 39172-39178.
81. Zhu L, Yan W, Rodriguez-Canales J, Rosenberg AM, Hu N, et al. (2011) MicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cells. Am J Cancer Res 1(5): 574-584.
82. Gao W, Xu J, Liu L, Shen H, Zeng H, et al. (2012) A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer. Biomed Pharmacother 66(1): 21-8.
83. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299(4): 425-436. (Pubitemid 351185951)
84. Yantiss RK, Goodarzi M, Zhou XK, Rennert H, Pirog EC (2009) Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol 33(4): 572-582.
85. Li Y, Tan W, Neo TW, Aung MO, Wasser S, et al. (2009) Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 100(7): 1234-1242.
86. Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, et al. (2011) Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog doi: 10.1002/mc.21864
87. Fang L, Deng Z, Shatseva T, Yang J, Peng C, et al. (2011) MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin- b8. Oncogene 30(7): 806-821.
88. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14(9): 2690-2695.
89. Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, et al. (2012) The miR-106b-25 cluster targets Smad7, activates TGF- b signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene doi: 10.1038/onc.2012.11
90. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P (2006) MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24(29): 4677-4684. (Pubitemid 46630931)
91. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25(5): 387-392. (Pubitemid 47362758)
92. Guo Y, Chen Z, Zhang L, Zhou F, Shi S, et al. (2008) Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 68(1): 26-33. (Pubitemid 351380102)
93. Tchernitsa O, Kasajima A, Schäfer R, Kuban RJ, Ungethüm U, et al. (2010) Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J Pathol 222(3): 310-319.
94. Barshack I, Meiri E, Rosenwald S, Lebanony D, Bronfeld M, et al. (2010) Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression. Int J Biochem Cell Biol 42(8): 1355-1362.
95. Xi Y, Formentini A, Chien M, Weir DB, Russo JJ, et al. (2006) Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights 2: 113-121.